Funding for this research was provided by:
Pfizer
Article History
Received: 24 May 2021
Accepted: 19 August 2021
First Online: 26 October 2021
Declarations
:
: The authors declare that they have no conflict of interest.
: N Masuda has received honoraria from AstraZeneca, Chugai, Eisai, Eli Lilly, Pfizer Inc, and Takeda and research funding from AstraZeneca, Chugai, Eisai, Eli Lilly, Daiichi Sankyo, Kyowa-Kirin, MSD, Novartis, and Pfizer Inc; H Iwata has received honoraria and research funding from AstraZeneca and Pfizer Inc and fees for promotional materials from AstraZeneca; M Toi has received honoraria from AstraZeneca, Chugai, Eisai, Eli Lilly, Genomic Health Institute, Kyowa-Hakko Kirin, MSD, Novartis, Pfizer Inc, Taiho, and Takeda; research funding from AstraZeneca, Chugai, Eli Lilly, Novartis, Pfizer Inc, and Taiho; served as a consultant/independent contractor for Kyowa-Hakko Kirin; and served on the advisory board for Genomic Health Institute; N Kosaka is an employee of Pfizer Inc.